Skip to main content
. 2016 May 11;7(4):452–458. doi: 10.1111/1759-7714.12353

Table 2.

Adverse reactions observed among the 52 patients in the study

Grade 0 1 2 3 4 Incidence rate (%) Incidence rate of grade 3, 4 (%)
Leukopenia 35 3 13 1 0 32.7 1.9
Neutropenia 24 6 15 7 0 53.8 13.5
Thrombocytopenia 51 0 0 1 0 1.9 1.9
Nausea and vomiting 25 12 11 4 0 51.9 7.7
Elevated transaminase 40 6 5 1 0 23.1 1.9
Rash 49 2 1 0 0 5.7 0
Fatigue 51 10 3 0 0 25.0 0